Who has invested in Edgewise Therapeutics?

OrbiMed, Novo Holdings, RA Capital, Viking Global, Venrock, Cormorant Asset Management are named among the investors backing Edgewise Therapeutics.

Edgewise Therapeutics Funding: $495M Raised, Growth (2024)

Edgewise Therapeutics funding overview

Edgewise Therapeutics is a Biotech company based in Boulder, CO. Edgewise Therapeutics has raised $495M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Growth announced in January 2024. The round record for Edgewise Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include OrbiMed, Novo Holdings, RA Capital, Viking Global, Venrock, Cormorant Asset Management and 3 others. 9 distinct backers are named across the disclosed rounds.

Edgewise Therapeutics at a glance

Total raised: $495M
Latest round: Growth
Latest round date: January 2024
Industry: Biotech
Headquarters: Boulder, CO
Notable investors: OrbiMed, Novo Holdings, RA Capital, Viking Global, Venrock, Cormorant Asset Management, Janus Henderson, Deerfield Management

Frequently asked about Edgewise Therapeutics funding

How much has Edgewise Therapeutics raised?: Edgewise Therapeutics has raised $495M in total disclosed funding across the rounds on record.
Who has invested in Edgewise Therapeutics?: OrbiMed, Novo Holdings, RA Capital, Viking Global, Venrock, Cormorant Asset Management are named among the investors backing Edgewise Therapeutics.
What was the latest Edgewise Therapeutics funding round?: The most recent disclosed round is a Growth, announced in January 2024.
Where is Edgewise Therapeutics based?: Edgewise Therapeutics is based in Boulder, CO.
What sector does Edgewise Therapeutics operate in?: Edgewise Therapeutics is tracked under Biotech from Boulder, CO, with $495M in disclosed funding.
When did Edgewise Therapeutics last raise?: The last disclosed Edgewise Therapeutics round closed in January 2024 at Growth.

We update the Edgewise Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Boulder and their backers are listed below.

Edgewise Therapeutics Funding: $495M Raised, Growth (2024)

Edgewise Therapeutics funding overview

Edgewise Therapeutics at a glance

Frequently asked about Edgewise Therapeutics funding

Edgewise Therapeutics founders (1)

Companies related to Edgewise Therapeutics (40)

Browse related funding lists (7)